Clavis

Cytovation appoints Olav Hellebø to its Board of Directors

Retrieved on: 
Wednesday, July 5, 2023
IESE Business School, Schering-Plough, Biotechnology, Clavis, Bachelor of Business Administration, MBA, ReNeuron, Business administration, Novartis, Hofstra University, Prostate cancer, Pharmaceutical industry

Bergen, Norway, July 5th, 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy CyPep-1, announces the appointment of Olav Hellebø to its Board of Directors.

Key Points: 
  • Bergen, Norway, July 5th, 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy CyPep-1, announces the appointment of Olav Hellebø to its Board of Directors.
  • Mr. Hellebø brings extensive international leadership experience, both in the US and Europe, across major pharmaceutical and biotechnology companies.
  • Olav currently serves on the Board of Antev, a UK-based private biotechnology company with a focus on prostate cancer.
  • Stein Christian Mohn, Chairman at Cytovation said: “We are very pleased to welcome Olav to our Board of Directors.

ID Quantique expands the XG Series with the launch of the Clavis XG: IDQ's long distance and backbone Quantum Key Distribution (QKD) solution, the ultimate in quantum-safe security

Retrieved on: 
Wednesday, May 11, 2022
Communication, QNET, IDQ, Network address, QRNG, IQT, Clavis, QKD, Confidentiality, Solution, Technology, XG, Back Door Channels: The Price of Peace, Risk, Cryptocurrency

GENEVA, May 11, 2022 /PRNewswire/ --ID Quantique, the world leader in quantum cybersecurity solutions, today launched the Clavis XG at the Inside Quantum Technology conference (IQT).

Key Points: 
  • GENEVA, May 11, 2022 /PRNewswire/ --ID Quantique, the world leader in quantum cybersecurity solutions, today launched the Clavis XG at the Inside Quantum Technology conference (IQT).
  • It expands the XG Series with higher key throughput and extended distance range, aiming at providing the highest level of trust to governments and enterprises for future proof data protection.
  • It is also designed as a platform to offer "QKD as a Service" to a wider range of customers.
  • Increased geopolitical and commercial pressure, technological advancements and malicious actors are putting our data confidentiality and sovereignty at risk.

ID Quantique expands the XG Series with the launch of the Clavis XG: IDQ's long distance and backbone Quantum Key Distribution (QKD) solution, the ultimate in quantum-safe security

Retrieved on: 
Wednesday, May 11, 2022
Communication, QNET, IDQ, Network address, QRNG, IQT, Clavis, QKD, Confidentiality, Solution, Technology, XG, Back Door Channels: The Price of Peace, Risk, Cryptocurrency

GENEVA, May 11, 2022 /PRNewswire/ --ID Quantique, the world leader in quantum cybersecurity solutions, today launched the Clavis XG at the Inside Quantum Technology conference (IQT).

Key Points: 
  • GENEVA, May 11, 2022 /PRNewswire/ --ID Quantique, the world leader in quantum cybersecurity solutions, today launched the Clavis XG at the Inside Quantum Technology conference (IQT).
  • It expands the XG Series with higher key throughput and extended distance range, aiming at providing the highest level of trust to governments and enterprises for future proof data protection.
  • It is also designed as a platform to offer "QKD as a Service" to a wider range of customers.
  • Increased geopolitical and commercial pressure, technological advancements and malicious actors are putting our data confidentiality and sovereignty at risk.